Showing results (551-560 of 629) with videos related to
Sort By:
Pageof 63
Journal of Affective Disorders|May 15, 2015
Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker?B Panizzutti, C Gubert, A L Schuh, et al.Journal of Affective Disorders|December 1, 2009
A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorderS Dodd, J Kulkarni, L Berk, et al.Journal of Affective Disorders|February 28, 2007
History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorderM Berk, S Dodd, P Callaly, et al.Schizophrenia Research|March 30, 2010
Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early interventionS M Francey, B Nelson, A Thompson, et al.Schizophrenia Research|March 27, 2013
Differences between first episode schizophrenia and schizoaffective disorderS M Cotton, M Lambert, B G Schimmelmann, et al.Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Inflammation and late-life depressive symptomsM Forbes, M Lotfaliany, B Mengist, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|March 2, 2016
Physical health comorbidities in women with personality disorder: Data from the Geelong Osteoporosis StudyS E Quirk, A L Stuart, S L Brennan-Olsen, et al.Plos Pathogens|June 4, 2020
Tn-Seq reveals hidden complexity in the utilization of host-derived glutathione in Francisella tularensisKathryn M Ramsey, Hannah E Ledvina, Tenayaann M Tresko, et al.American Heart Journal|February 26, 2000
Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunctionJ E Udelson, C A DeAbate, M Berk, et al.BMC Neurology|February 2, 2020
Protocol of a randomized open label multicentre trial comparing continuous intrajejunal levodopa infusion with deep brain stimulation in Parkinson's disease - the INfusion VErsus STimulation (INVEST) studyD van Poppelen, V Sisodia, R J de Haan, et al.Pageof 63